Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) FCF Margin (2012 - 2026)

Updated

Enanta Pharmaceuticals' FCF Margin was -69.50% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 164.24 percentage points from 94.74% a year earlier and down 27.71 percentage points from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) FCF Margin (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Enanta Pharmaceuticals' FCF Margin was -56.60% through Jun 30, 2026, up 10.63 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at -49.24%, up 93.75 percentage points from FY2024.

  • FCF Margin shows a five-year change of -53.85 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, FCF Margin was -142.99% in FY2024 (-1.32 pp), -141.67% in FY2023 (-40.81 pp), -100.87% in FY2022 (-27.99 pp) and -72.88% in FY2021 (-77.49 pp).
  • The fiscal Q3 2026 figure marks the lowest quarterly FCF Margin since fiscal Q2 2025.
  • Compared with a year earlier, FCF Margin was higher in five of the last eight quarters, with an average year-over-year change of +41.65 percentage points.
  • The best year-over-year quarter for FCF Margin over five years was fiscal Q3 2025 (a gain of 213.36 percentage points); the worst was fiscal Q3 2026 (a drop of 164.24 percentage points).
  • Per Business Quant data, ENTA's FCF Margin in the three fiscal quarters before Q3 2026 was -41.79% (Q2 2026), -63.62% (Q1 2026) and -52.54% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - -69.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.50%
Mar 31, 2026 -41.79%
Dec 31, 2025 -63.62%
Sep 30, 2025 -52.54%
Jun 30, 2025 94.74%
Mar 31, 2025 -107.37%
Dec 31, 2024 -150.63%
Sep 30, 2024 -132.48%
Jun 30, 2024 -118.62%
Mar 31, 2024 -177.49%
Dec 31, 2023 -143.17%
Sep 30, 2023 -121.33%
Jun 30, 2023 -181.45%
Mar 31, 2023 -90.85%
Dec 31, 2022 -164.50%
Sep 30, 2022 -83.53%
Jun 30, 2022 -153.26%
Mar 31, 2022 -141.32%
Dec 31, 2021 -49.31%
Sep 30, 2021 -89.31%
API Access

Enanta Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ENTA&period=max&api_key=YOUR_API_KEY